Valuation: Sysmex Corporation

Market Cap 994B 6.27B 5.45B 5.1B 4.66B 8.81B 598B 8.92B 59.65B 23.41B 299B 23.56B 23.05B P/E 2027 *
25x
P/E 2028 * 20.4x
Enterprise Value 1,013B 6.39B 5.55B 5.19B 4.75B 8.97B 609B 9.09B 60.77B 23.85B 304B 24B 23.48B EV / Sales 2027 *
1.89x
EV / Sales 2028 * 1.79x
Free-Float
72.3%
Yield 2027 *
2.36%
Yield 2028 * 2.46%
1 day-0.46%
1 week+2.16%
Current month+2.16%
1 month+4.38%
3 months+23.84%
6 months+7.43%
Current year+5.90%
1 week 1,553
Extreme 1553
1,644
1 month 1,494
Extreme 1494
1,689
Current year 1,246
Extreme 1246
1,689
1 year 1,246
Extreme 1246
2,086
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 31/03/2018
Director of Finance/CFO 56 -
President 65 31/03/2026
Director TitleAgeSince
Chairman 76 31/03/2013
Director/Board Member 65 31/05/2019
Director/Board Member 71 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+2.16%-19.99%-47.25% 6.25B
+2.13%+2.23%-17.54%+0.29% 183B
-0.08%+0.25%-3.85%+2.24% 110B
+2.46%+4.09%+14.53%+75.37% 61.72B
+0.08%+3.32%+36.30%+52.57% 54.98B
+3.76%+7.02%+2.70%-34.61% 47.02B
-5.88%-11.78% - - 32.16B
+0.44%+11.38%+8.66%-31.01% 31.19B
-0.69%+2.65%+46.92%-7.06% 24.7B
-0.40%+0.25%+4.78%+2.55% 22.68B
Average +0.14%+2.12%+8.06%+1.46% 57.37B
Weighted average by Cap. +0.89%+2.64%+1.48%+8.93%

Financials

2027 *2028 *
Net sales 536B 3.39B 2.94B 2.75B 2.52B 4.75B 323B 4.81B 32.2B 12.63B 161B 12.72B 12.44B 566B 3.57B 3.1B 2.9B 2.66B 5.01B 340B 5.08B 33.96B 13.33B 170B 13.41B 13.12B
Net income 40.28B 254M 221M 207M 189M 357M 24.22B 362M 2.42B 949M 12.1B 955M 934M 49.11B 310M 269M 252M 230M 435M 29.53B 441M 2.95B 1.16B 14.76B 1.16B 1.14B
Net Debt 18.61B 117M 102M 95.46M 87.32M 165M 11.19B 167M 1.12B 438M 5.59B 441M 431M 18.81B 119M 103M 96.51M 88.28M 167M 11.31B 169M 1.13B 443M 5.65B 446M 436M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
07/08/26 JP¥1,635.00 -0.37% 1,110,400
06/08/26 JP¥1,641.00 +0.89% 1,809,300
05/08/26 JP¥1,626.50 +0.99% 2,640,500
04/08/26 JP¥1,610.50 +0.91% 2,058,900
03/08/26 JP¥1,596.00 -0.19% 2,866,700
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,641.00JPY
Average target price
1,774.29JPY
Spread / Average Target
+8.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock